Overview

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine if topical SB-275833 ointment, 1% is more effective than a placebo ointment in the treatment of primary impetigo.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Retapamulin